Prawo i regulacje · 23/04/2013

Lipomed Seeks FDA Approval for Controlled Substance Importation

Lipomed, a pharmaceutical company, has submitted a notice of application to the FDA for permission to import controlled substances, a move that could impact the distribution of certain medications.